AVXL

Anavex Life Sciences Corp. NMS · AVXL

$2.52 -0.03 (-1.37%)

Neutral · -0.17σ

+ Compare Open in Sniper

Valuation

Market cap $0.2B

P/E (ttm) —

Forward P/E -4.6

Beta (5y) 1.14

Shares out 92.7M

Div yield —

Profitability & returns

ROE -33.6%

Net margin —

FCF margin —

Debt / equity —

Trading information

Last price $2.52

Day range $2.46 – $2.56

52-wk range $2.26 – $5.32

Avg volume 1.2M

RSI (2) 49.3

Trend zone Neutral

52-week range · today's price

$2.26$5.32

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-07-23

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase …